Table 4.

Distribution of Gametocytes Prevalence by Treatment Group

Treatment Arm	Treatment Arm: SP-AQ		Treatment Arm: DHA-PQ		Treatment Arm: Control
	n	%	n	%	n	%
From days 1–30 (during and after SMC round 1), P = .807
Gametocyte+	2	22.2	3	33.3	4	44.4
From day 31–60 (during and after SMC round 2), P = .0004
Gametocyte+	1	9.1	0	0.0	10	90.9
From day 61–90 (during and after SMC round 3), P = .0017
Gametocyte+	0	0.0	1	11.1	8	88.9
From day 91–120 (during and after SMC round 4), P = .0072
Gametocyte+	0	0.0	1	12.5	7	87.5
From day 1–120 (during and after All SMC rounds), P < .0001
Gametocyte+	3	8.1	5	13.5	29	78.4

Abbreviations: DHA-PQ, dihydroartemisinin-piperaquine; SMC, seasonal malaria chemoprevention; SP-AQ, sulfadoxine-pyrimethamine plus amodiaquine.